As shown in Figure 3(a), IL-10 was increased in ND AML patients (n = 40) compared with healthy controls (n = 15) and patients in CR (n = 25) (H = 21.24, P < 0.001). This evidence concerns the gene IL10 and acute myeloid leukemia.